All News

Article

Best of 2020: The COVID-19 Global Rheumatology Registry

Kathryn H. Dao, M.D. Dec 24, 2020

What started out as online tweets and sharing newsfeed and case reports, has progressed to the formation of the COVID-19 Global Rheumatology Alliance, whose mission is to create an international rheumatology registry of patients affected by the disease in order to better understand the disease and guide clinicians in assessing and treating patients.

Article

Best of 2020: A Rheumatologist’s Tips: Telemedicine in 6 Easy Steps

Kathryn H. Dao, M.D. Dec 23, 2020

Ready for telemedicine/telerheumatology?

Once you and your patient agree on a virtual visit, the following suggestions may help facilitate the interaction. If you have the ability and the capacity, record the visit.

#BestACR20Tweets RT @drpnash : Safety Profile of Baricitinib for the Treatment of Rheumatoid Arthritis up to 8.4 Years: An Updated Integrated Safety Analysis https://t.co/bSkedaRwfv #RA #Baricitinib #safety 13000 pt/yrs 8.4 yrs F/U no new safety signals VTE 0.5/100 pt yrs

https://bit.ly/38Cw8D9

The core problem of COI amongst docs is that the profession does not really care. Disclosure is not the solution. Divestment and recusal are, but no one inside wants to do that. This was a case of failure to disclose (on a large scale) and the punishment was a promotion https://t.co/Q384TNnPy2

https://twitter.com/propublica/status/1342866712933376000

#BestACR20Tweet RT @KDAO2011 : Abstr#0545 TCZ and Tofa may be safe in patients with resolved Hepatitis B infection. MGH study of 20 pts given TCZ or Tofa, followed 4 years; 25% on antivirals, but no cases of transaminitis from HBV or reactivation of HBV seen. #ACR20 @rheumnow

#BestACR20Tweets RT @KDAO2011 : Abstr#0013 TEASER! Colchicine may improve COVID19 outcomes in hospitalized patients. 50 pts 1:1 colchicine vs. PCB + standard of care: Colchicine group 2X more likely to be d/c from hospital, and less likely to die. Larger studies needed! #ACR20

#BestACR20Tweets RT @KDAO2011 : #ACR20 Abstr#0431 Hydroxychloroquine Use Was Not Associated with QTc Length in a Large Cohort of SLE and RA Patients @rheumnow https://t.co/7yn0fK1tfn

https://bit.ly/3hhGH2h

#BestACR20Tweets RT @uptoTate : Claims-based "big data" reveals PsA pts had "arthritis" coding prior to formal dx and coding for enthesitis, axial dz, and arthritis increased prior to PsA dx. Coding diff between treating specialties also noted. #ACR20 https://t.co/naeRPFZdap https://t.co/E4XvlZSsX6

https://bit.ly/37KhPNC

Content Download Available! Download our document on arthritis myths below. https://t.co/2Kxpou4Fbz https://t.co/iPIqR92ME1

https://bit.ly/2KzYdD0

#Bestof2020: A Rheumatologist’s Tips: Telemedicine in 6 Easy Steps https://t.co/p8B0dDTktT https://t.co/sHBisreYnW

https://bit.ly/37HohFd

#Bestof2020: Rheumatic Disease Drugs and COVID-19 https://t.co/82uGbNqm9R https://t.co/U0WyTL5kYZ

https://bit.ly/34EX1W6

#ACR20 Mid Meeting Recap: Gout https://t.co/MhaYjotrmb https://t.co/R4dOrSlFl6

https://bit.ly/3pgR35E

#BestACR20Tweets RT @uptoTate :Dactylitis is a clinical indicator for an aggressive phenotype of PsA categorized w/ significantly greater TJC, SJC, CRP, US synovitis/erosions in very early DMARD naïve pts. #ABS0312 #ACR20 https://t.co/d2ZjXRgvkE https://t.co/60n5pNfx9O https://t.co/EvsR0aJtXJ

#BestACR20Tweets RT @RichardPAConway : Dr Fernandez-Diaz on abatacept in RA-ILD in 263 patients. Abatacept appears safe and effective. Equivalent to RTX. Good option as s/c admin @rheumnow #ACR20 Abstr#0233 #ACRbest https://t.co/yqV6BoKy4s https://t.co/7jUASw5D2f

https://bit.ly/3h7hLum

Make sure you check out the RheumNow podcast on Soundcloud or Apple/Android devices. New episodes every week! https://t.co/wjBWCrKL34 https://t.co/3z2aWfB95V

https://bit.ly/3pjQqJ2

#Bestof2020 Goodwill Wednesday https://t.co/2mJ0xJNChL https://t.co/5SP90IVpwg

https://bit.ly/3nSZUKx

#BestACR20Tweets RT @RichardPAConway : Really important study by @SattuiSEMD on high prevalence of frailty and its impact on QOL in PMR #ACR20 @rheumnow Abstr#422 https://t.co/QzDYGsqDeJ

Autoinflammatory & Still's Disease Panel #acr20 Dr. Jack Cush leads a panel of experts regarding Still's Disease and ACR 2020. https://t.co/4GmM56l1cb https://t.co/WbXMUtz6Up

https://bit.ly/3h8CIoG

#BestACR20Tweets RT @bella_mehta : Another addition to - where you live matters! #EosinophilicFasciitis regional clustering seen in proximity to ash, landfills, chemical release sites, and combustion facilities + clustering seen in low SES and minority communities #ACR20 https://t.co/VSMYIO7EuX

Psoriatic Arthritis Panel Discussion Drs. Artie Kavanaugh, Jack Cush, Eric Ruderman and Alexis Ogdie-Beatty discuss novel issues and new drug studies from #ACR20. https://t.co/KLEBuWNHkn https://t.co/ERIT7f9rNq

https://bit.ly/3rfXurg

Topics

All News

Best of 2020: The COVID-19 Global Rheumatology Registry

Best of 2020: A Rheumatologist’s Tips: Telemedicine in 6 Easy Steps

Do you get our email newsletter?